ATAlexandra L. Tabakin

Alexandra L. Tabakin

*This is an algorithmically generated author record based on publicly available information.

Alexandra L. Tabakin has a total of 100 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Finish What’s Started: American Urogynecologic Society Pelvic Floor Disorder Week Abstract Publishing Rates

    by Alexandra L. Tabakin, Jessica Kahan, Jinsol Hyun, Wai Lee, Harvey A. Md Winkler, Dara F. Shalom

    Importance: Little is known regarding the publication rate of abstracts presented at the American Urogynecologic Society (AUGS) Pelvic Floor Disorder Week (PFD). Objective: Our aims were to determine contemporary publication rates of AUGS PFD oral and poster presentation abstracts and factors associated with publication. Study Design: In this retrospective study, we reviewed short and long oral and poster abstracts from 2019 and 2020 AUGS PFD. Article publication rates were calculated. Statistical analysis was performed with Kruskal-Wallis and χ 2 tests. Multivariable logistic regression was used to assess factors associated with likelihood of publication. Results: We identified 831 abstracts from the 2019 and 2020 PFD. Publication rates were 23.5%, 45.4%, and 53.3% at 1, 2, and 3 years (55.1% overall) with median time to publication of 16 months. For published abstracts, median journal impact factor was 2 with median principal investigator H-index of 15. Long and short podium presentations were 4 (95% confidence interval [CI], 2.2–7.6) and 1.8 times (CI, 1.2–2.5), respectively, as likely to be published than poster presentations (both P < 0.01). Resident/fellow (odds ratio [OR] 1.7, [95% CI, 1.2–2.4], P < 0.01) and female first-authorship (OR 1.4, [95% CI, 1.0–2.0], P = 0.04) and randomized control trials (OR 2.33, [95% CI, 1.2–4.7], P = 0.02) were predictive of publication. Conclusions: Nearly half the abstracts from AUGS PFD 2019 and 2020 are unpublished. Abstracts with oral presentations, female and trainee first authors, and randomized control trials were more likely to be published. Ultimately, timely publication is critical for ensuring reliability of evidence.

  • Open Access

    How Do I Match? A Survey Study on the Impact of Step 1 Becoming Pass/Fail

    by Benjamin J. Lichtbroun, Aravind Rajagopalan, Kevin Chua, Alexandra Tabakin, John Pfail, Chrystal Chang, Danielle Velez, Ji Hae Park, Vignesh T. Packiam, Thomas L. Jang, et al.


  • Case log trends of urogynecology and reconstructive pelvic surgery fellows: A comparison of urology‐ and gynecology‐based fellowship programs

    by Alexandra L. Tabakin, Rohan Sawhney, Adam M. Daily, Harvey A. Winkler, Dara F. Shalom, Justina Tam, Wai Lee

    Aims: Urogynecology and Reconstructive Pelvic Surgery (URPS) fellowship can be pursued after completion of either a urology (URO) or obstetrics and gynecology (GYN) residency. Our aim is to determine differences in graduating fellow cohort (GFC) case logs between URO‐ and GYN‐based URPS programs.Methods: Accreditation Council for Graduate Medical Education case logs for URPS GFCs in both GYN‐ and URO‐based programs were analyzed for the 2019–2023 academic years (AY). Unpaired t‐tests with Welch's correction were used to compare annual mean logged cases between URO‐ versus GYN‐based GFCs for select surgical categories and the top 11 most logged index cases.Results: GYN‐based GFCs logged more cases for all pelvic organ prolapse (POP) categories including surgery on apical POP, anterior wall POP, and posterior wall POP (all p < 0.01), while URO‐based GFCs logged more cases for surgery on the urinary system (p = 0.03). For the top 11 logged procedures, URO‐based GFCs logged more sacral neuromodulation cases (p = 0.02), whereas GYN‐based GFCs logged more slings, vaginal hysterectomies, minimally‐invasive hysterectomies, vaginal apical POP, vaginal posterior POP, vaginal anterior POP, and minimally‐invasive apical POP cases (all p < 0.01). There was no difference between URO‐ and GYN‐based GFCs for complex urodynamics, cystoscopy with botox injection, or periurethral injection cases.Conclusions: URO‐based URPS fellows tend to graduate with more surgery on the urinary system and sacral neuromodulation cases, while GYN‐based fellows perform more slings, hysterectomies, and POP surgery. These findings may help fellowships better understand potential differences in training among graduates from URO‐ and GYN‐based programs and encourage collaboration to lessen these discrepancies.

  • ATTITUDES AMONG 2023 UROLOGY RESIDENCY APPLICANTS REGARDING DOBBS V. JACKSON WOMEN’S HEALTH ORGANIZATION

    by Chloe Peters, Casey Seideman, Sophie Kauderer, John Gore, Akanksha Mehta, Eric A. Singer, Alexandra Tabakin, Simone Thavaseelan, Vijaya Md. Vemulakonda, Tasha Posid, et al.

  • Open Access

    The Impact of COVID-19 on Surgical Training and Education

    by Melinda Z. Fu, Raeesa Islam, Eric A. Singer, Alexandra L. Tabakin

    The COVID-19 pandemic disrupted conventional medical education for surgical trainees with respect to clinical training, didactics, and research. While the effects of the COVID-19 pandemic on surgical trainees were variable, some common themes are identifiable. As hordes of COVID-19 patients entered hospitals, many surgical trainees stepped away from their curricula and were redeployed to other hospital units to care for COVID-19 patients. Moreover, the need for social distancing limited traditional educational activities. Regarding clinical training, some trainees demonstrated reduced case logs and decreased surgical confidence. For residents, fellows, and medical students alike, most didactic education transitioned to virtual platforms, leading to an increase in remote educational resources and an increased emphasis on surgical simulation. Resident research productivity initially declined, although the onset of virtual conferences provided new opportunities for trainees to present their work. Finally, the pandemic was associated with increased anxiety, depression, and substance use for some trainees. Ultimately, we are still growing our understanding of how the COVID-19 pandemic has redefined surgical training and how to best implement the lessons we have learned.


  • Open Access

    The role of chromodomain helicase DNA binding protein 1 (CHD1) in promoting an invasive prostate cancer phenotype

    by Aparna Kareddula, Daniel J. Medina, Whitney Petrosky, Sonia Dolfi, Irina Tereshchenko, Kelly Walton, Hana Aviv, Evita Sadimin, Alexandra L. Tabakin, Eric A. Singer, et al.

    Prostate cancer (PCa) phenotypes vary from indolent to aggressive. Molecular subtyping may be useful in predicting aggressive cancers and directing therapy. One such subtype involving deletions of chromodomain helicase DNA binding protein 1 (CHD1), a tumor suppressor gene, are found in 10–26% of PCa tumors. In this study, we evaluate the functional cellular effects that follow CHD1 deletion. CHD1 was knocked out (KO) in the non-tumorigenic, human papillomavirus 16 (HPV16)-immortalized prostate epithelial cell line, RWPE-1, using CRISPR/Cas9. In vitro assays such as T7 endonuclease assay, western blot, and sequencing were undertaken to characterize the CHD1 KO clones. Morphologic and functional assays for cell adhesion and viability were performed. To study expression of extracellular matrix (ECM) and adhesion molecules, a real-time (RT) profiler assay was performed using RWPE-1 parental, non-target cells (NT2) and CHD1 KO cells. Compared to parental RWPE-1 and non-target cells (NT2), the CHD1 KO cells had a smaller, rounder morphology and were less adherent under routine culture conditions. Compared to parental cells, CHD1 KO cells showed a reduction in ECM and adhesion molecules as well as a greater proportion of viable suspension cells when cultured on standard tissue culture plates and on plates coated with laminin, fibronectin or collagen I. CHD1 KO cells showed a decrease in the expression of secreted protein acidic and rich in cysteine (SPARC), matrix metalloproteinase 2 (MMP2), integrin subunit alpha 2 (ITGA2), integrin subunit alpha 5 (ITGA5), integrin subunit alpha 6 (ITGA6), fibronectin (FN1), laminin subunit beta-3 precursor (LAMB3), collagen, tenascin and vitronectin as compared to parental and NT2 cells. These data suggest that in erythroblast transformation specific (ETS) fusion-negative, phosphatase and tensin homolog (PTEN) wildtype PCa, deletion of CHD1 alters cell-cell and cell-matrix adhesion dynamics, suggesting an important role for CHD1 in the development and progression of PCa.


  • Editorial Comment

    by Alexandra Tabakin, Eric A. Singer

  • Polypoid Endometriosis Presenting as a Renal Cortical Tumor

    by Alexandra L. Tabakin, John L. Dutton, Aisha Fatima, Evita Sadimin, Thomas L. Jang